Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis (Q38753435)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 February 2017

Language	Label	Description	Also known as
English	Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis	scientific article published on 25 February 2017

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

0 references

Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

6 September 2017

1 reference

based on heuristic

inferred from title

Wellington Martins

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

T N Bechtejew

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M N Nadai

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C O Nastri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

25 February 2017

1 reference

Europe PubMed Central

6 September 2017

Ultrasound in Obstetrics and Gynecology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

50

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

315-323

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Definition and prevalence of subfertility and infertility

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Cumulative success rates following mild IVF in unselected infertile patients: a 3-year, single-centre cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Affordable ART: a different perspective.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Ovarian hyperstimulation syndrome: pathophysiology and prevention

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Why do couples discontinue unlimited free IVF treatments?

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Why do couples drop-out from IVF treatment? A prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Mild approaches in assisted reproduction--better for the future?

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Friendly IVF: the way of the future?

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Towards a more physiological approach to IVF.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Synthesizing Evidence from Diagnostic Accuracy TEsts: the SEDATE guideline

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

GRADE guidelines: 3. Rating the quality of evidence

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Comparison of mild stimulation and conventional stimulation in ART outcome.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

"Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Congenital malformations among babies born following letrozole or clomiphene for infertility treatment

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\ICSI procedures: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Effectiveness of the antagonist/letrozole protocol for treating poor responders undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.17442

21 January 2018

Identifiers

10.1002/UOG.17442

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236310%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38753435&oldid=1782967461"